A detailed history of Sabal Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Sabal Trust CO holds 5,426 shares of LLY stock, worth $4.32 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
5,426
Previous 5,435 0.17%
Holding current value
$4.32 Million
Previous $4.92 Million 2.3%
% of portfolio
0.26%
Previous 0.29%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $6,949 - $8,640
-9 Reduced 0.17%
5,426 $4.81 Million
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $15,947 - $19,998
22 Added 0.41%
5,435 $4.92 Million
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $198,387 - $265,413
335 Added 6.6%
5,413 $4.21 Million
Q4 2023

Jan 24, 2024

SELL
$525.19 - $619.13 $247,364 - $291,610
-471 Reduced 8.49%
5,078 $2.96 Million
Q2 2023

Jul 20, 2023

BUY
$350.74 - $468.98 $91,893 - $122,872
262 Added 4.96%
5,549 $2.6 Million
Q1 2023

Apr 26, 2023

SELL
$310.63 - $364.82 $38,828 - $45,602
-125 Reduced 2.31%
5,287 $1.82 Million
Q4 2022

Jan 31, 2023

BUY
$321.55 - $374.67 $89,712 - $104,532
279 Added 5.44%
5,412 $1.98 Million
Q3 2022

Oct 18, 2022

BUY
$296.48 - $337.87 $32,019 - $36,489
108 Added 2.15%
5,133 $1.66 Million
Q2 2022

Jul 18, 2022

BUY
$278.73 - $327.27 $20,068 - $23,563
72 Added 1.45%
5,025 $1.63 Million
Q1 2022

Apr 14, 2022

SELL
$234.69 - $291.66 $210,282 - $261,327
-896 Reduced 15.32%
4,953 $1.42 Million
Q4 2021

Jan 21, 2022

SELL
$224.85 - $279.04 $26,082 - $32,368
-116 Reduced 1.94%
5,849 $1.62 Million
Q3 2021

Oct 18, 2021

BUY
$221.6 - $272.71 $110,800 - $136,355
500 Added 9.15%
5,965 $1.38 Million
Q2 2021

Jul 16, 2021

SELL
$180.55 - $233.54 $8,124 - $10,509
-45 Reduced 0.82%
5,465 $1.25 Million
Q1 2021

Apr 19, 2021

SELL
$164.32 - $212.72 $248,780 - $322,058
-1,514 Reduced 21.55%
5,510 $1.03 Million
Q4 2020

Jan 20, 2021

SELL
$130.46 - $172.63 $3,391 - $4,488
-26 Reduced 0.37%
7,024 $1.19 Million
Q3 2020

Oct 14, 2020

SELL
$146.22 - $169.13 $40,210 - $46,510
-275 Reduced 3.75%
7,050 $1.04 Million
Q2 2020

Jul 13, 2020

SELL
$136.42 - $164.18 $40,925 - $49,254
-300 Reduced 3.93%
7,325 $1.2 Million
Q1 2020

Apr 14, 2020

BUY
$119.05 - $147.35 $72,144 - $89,294
606 Added 8.63%
7,625 $1.06 Million
Q4 2019

Jan 14, 2020

SELL
$106.92 - $132.43 $52,604 - $65,155
-492 Reduced 6.55%
7,019 $923,000
Q3 2019

Oct 15, 2019

BUY
$106.79 - $116.16 $40,153 - $43,676
376 Added 5.27%
7,511 $840,000
Q2 2019

Jul 17, 2019

SELL
$110.79 - $129.32 $32,683 - $38,149
-295 Reduced 3.97%
7,135 $790,000
Q1 2019

Apr 12, 2019

SELL
$111.31 - $131.02 $48,419 - $56,993
-435 Reduced 5.53%
7,430 $964,000
Q4 2018

Feb 01, 2019

BUY
$105.9 - $118.64 $79,425 - $88,980
750 Added 10.54%
7,865 $911,000
Q3 2018

Oct 16, 2018

BUY
$85.86 - $107.31 $15,884 - $19,852
185 Added 2.67%
7,115 $764,000
Q2 2018

Jul 16, 2018

BUY
$75.7 - $86.88 $24,981 - $28,670
330 Added 5.0%
6,930 $591,000
Q1 2018

Apr 16, 2018

SELL
$74.21 - $87.6 $25,231 - $29,783
-340 Reduced 4.9%
6,600 $511,000
Q4 2017

Feb 07, 2018

BUY
$81.94 - $87.89 $40,970 - $43,945
500 Added 7.76%
6,940 $586,000
Q3 2017

Oct 17, 2017

BUY
$77.07 - $85.54 $496,330 - $550,877
6,440
6,440 $551,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sabal Trust CO Portfolio

Follow Sabal Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabal Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sabal Trust CO with notifications on news.